Full Circles Therapeutics
Company Type: Therapeutic development
Main focus: Developing novel non-viral gene-editing therapeutics
Company stage: Pre-clinical
Diseases: Autoimmune disorders, genetic diseases, and cancer
Genome-editing tool: CRISPR-Cas9
Funding stage: Venture - Series unknown
Location: Cambridge, Massachusetts, USA
Website: www.fullcirclestx.com
Pipeline:
Partners:
Full Circles Therapeutics is a biotechnology company dedicated to advancing and optimising non-viral gene-editing platforms. The company focuses on driving progress in genomic medicine through its proprietary nuclease editors and viral-free gene-editing technologies. Their platforms, including the enGager system, enable large transgene knock-ins of up to 20 kb, offering safer and more efficient delivery options.